TERN Stock Analysis: Buy, Sell, or Hold?
TERN - Terns Pharmaceuticals, Inc. Common Stock
$52.95
0.02 (0.04%)
▲
5d:
+0.0%
30d:
+0.44%
90d:
+43.81%
BUY
MODERATE Confidence
Analysis Updated: May 4, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When TERN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TERN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: TERN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TERN is currently trading at $52.95, which is considered fair based on recent price action.
Technical Outlook: Technically, TERN is in a strong uptrend. The price is currently testing key support at $52.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TERN is in a strong uptrend. The price is currently testing key support at $52.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
57/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Protect Your Profits
TERN is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($53.00)
Support & Resistance Levels
Support Level
$52.71
Resistance Level
$52.98
Current Trend
Strong Uptrend
Technical data as of
May 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-35.99
Wall Street Target
$53.00
(+0.1%)
Share & Embed Analysis
Last updated: June 23, 2026 11:00 PM ET
Data refreshes hourly during market hours. Next update: 12:00 AM
Data refreshes hourly during market hours. Next update: 12:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TERN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Emil Kuriakose
SELL
942 shares
2026-04-01
Amy L Burroughs
SELL
14583 shares
2026-03-16
Amy L Burroughs
SELL
14583 shares
2026-02-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
MNMD
Mind Medicine Inc |
STRONG BUY
11 analysts |
$29 | 62 BUY |
|
ALLO
Allogene Therapeutics Inc |
STRONG BUY
14 analysts |
$8 | 60 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 59 HOLD |
Advanced TERN Option Strategies
Professional options setups generated by AI based on today's TERN price and gamma walls.
